{"entity":{"type":"insider","cik":"0001945417","url":"/insider/0001945417","json_url":"/insider/0001945417.json","name":"Rock Edwin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":4,"first":"2022-11-16","last":"2024-06-24","span_basis":"filed_date"},"name_variants":[{"name":"Rock Edwin","source":"filing","n_filings":4,"first_seen":"2022-11-16","last_seen":"2024-06-24"}],"transactions":[{"id":2603230,"accession":"0001415889-24-017978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-017978","line_url":"/filing/0001415889-24-017978#line-2","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001945417","owner_name":"Rock Edwin","owner_display_name":"Rock Edwin","owner_url":"/insider/0001945417","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":115000.0,"shares_display":"115,000","price_per_share":0.2671,"price_display":"0.27","price_state":"stated","total_value":30716.5,"total_display":"30,716.50","total_whole":"30,717","shares_owned_after":680403.0,"shares_owned_after_display":"680,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-21","filed_date":"2024-06-24","scope":"insider"},{"id":2603223,"accession":"0001415889-24-017978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-017978","line_url":"/filing/0001415889-24-017978#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001945417","owner_name":"Rock Edwin","owner_display_name":"Rock Edwin","owner_url":"/insider/0001945417","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":190000.0,"shares_display":"190,000","price_per_share":0.2532,"price_display":"0.25","price_state":"stated","total_value":48108.0,"total_display":"48,108.00","total_whole":"48,108","shares_owned_after":565403.0,"shares_owned_after_display":"565,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-20","filed_date":"2024-06-24","scope":"insider"},{"id":8501881,"accession":"0001209191-23-050476","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050476","line_url":"/filing/0001209191-23-050476#line-2","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001945417","owner_name":"Rock Edwin","owner_display_name":"Rock Edwin","owner_url":"/insider/0001945417","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30403.0,"shares_display":"30,403","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":41956.14,"total_display":"41,956.14","total_whole":"41,956","shares_owned_after":375403.0,"shares_owned_after_display":"375,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-22","filed_date":"2023-09-25","scope":"insider"},{"id":8501876,"accession":"0001209191-23-050476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050476","line_url":"/filing/0001209191-23-050476#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001945417","owner_name":"Rock Edwin","owner_display_name":"Rock Edwin","owner_url":"/insider/0001945417","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":48300.0,"total_display":"48,300.00","total_whole":"48,300","shares_owned_after":345000.0,"shares_owned_after_display":"345,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-21","filed_date":"2023-09-25","scope":"insider"},{"id":6498163,"accession":"0001209191-22-062741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062741","line_url":"/filing/0001209191-22-062741#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001945417","owner_name":"Rock Edwin","owner_display_name":"Rock Edwin","owner_url":"/insider/0001945417","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":110000.0,"shares_display":"110,000","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":247500.0,"total_display":"247,500.00","total_whole":"247,500","shares_owned_after":310000.0,"shares_owned_after_display":"310,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-22","filed_date":"2022-12-27","scope":"insider"},{"id":6374871,"accession":"0001209191-22-057314","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-057314","line_url":"/filing/0001209191-22-057314#line-2","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001945417","owner_name":"Rock Edwin","owner_display_name":"Rock Edwin","owner_url":"/insider/0001945417","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":166000.0,"total_display":"166,000.00","total_whole":"166,000","shares_owned_after":200000.0,"shares_owned_after_display":"200,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-16","scope":"insider"},{"id":6374868,"accession":"0001209191-22-057314","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-057314","line_url":"/filing/0001209191-22-057314#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"GLYCOMIMETICS INC","issuer_ticker":"GLYC","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001945417","owner_name":"Rock Edwin","owner_display_name":"Rock Edwin","owner_url":"/insider/0001945417","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.43,"price_display":"1.43","price_state":"stated","total_value":143000.0,"total_display":"143,000.00","total_whole":"143,000","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001253689","name":"GLYCOMIMETICS INC","url":"/issuer/0001253689","role":"Officer (Chief Medical Officer)","n_filings":4,"first_seen":"2022-11-16","last_seen":"2024-06-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001945417","retrieved_at":"2026-08-25T02:36:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}